菌体显示精选的抗体,针对Staphylococcus aureus中的表面α乙诺酶
Wei-Chu Wang1, Chi-Hsin Lee1,2,3, Chao-Jung Wu1,2
1Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Biotechnology journal
|April 1, 2025
概括
研究人员开发了针对金黄色葡萄球菌 (Staphylococcus aureus alpha-enolase) 的特定抗体. 这些抗体显示出作为诊断工具和抗生素耐药性感染的替代疗法的潜力.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 黄金葡萄球菌是机会性感染和抗生素耐药性的主要原因.
- 在S. aureus表面的α-酶有助于宿主组织的侵入和生物膜的形成.
- 需要新的治疗策略来对抗黄金菌感染.
研究的目的:
- 使用菌体显示技术开发针对黄金色杆菌α-enolase的特定抗体.
- 评估这些抗体作为抗生素替代品的诊断和治疗潜力.
主要方法:
- 菌体显示单链可变片段 (scFv) 库的构建和选.
- 一只的免疫接种与重组的金黄色细菌α-enolase.
- 生物扫描,表位图绘制,交叉反应测定,ELISA和流细胞计用于抗体表征.
- 对临床S. aureus分离物的抗体特异性的验证,包括MRSA.
主要成果:
- 确定了五个具有高结合亲和度的scFv抗体克隆:SaS1,SaS2和SaL2.
- SaS1和SaS2表现出与S. aureus alpha-enolase的特定结合.
- SaL2显示与Streptococcus pneumoniae alpha-enolase的交叉反应性.
- 经验证的抗体特异性对甲素敏感和甲素耐药的金黄色细菌菌株.
结论:
- 开发了针对S. aureus. 的特定抗α-enolase抗体 (SaS1,SaS2).
- 鉴定了潜在的诊断和治疗药物来对抗金黄色细菌感染.
- 这些抗体代表了传统抗生素治疗的有希望的替代品.
相关概念视频
Special Staining Techniques
Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


